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Regulation of Btk Function by a
Major Autophosphorylation Site
Within the SH3 Domain
Hyunsun Park,*# Matthew I. Wahl,*²# homology domains, SH3, SH2, and SH1 (catalytic) (Tsu-
kada et al., 1993; Vetrie et al., 1993; Rawlings et al.,Daniel E. H. Afar,* Christoph W. Turck,³
David J. Rawlings,* Christina Tam,* 1993; Thomas et al., 1993). Mutations in the Btk gene
result inhuman X-linked agammaglobulinemia (XLA) andAndrew M. Scharenberg,§ Jean-Pierre Kinet,§
and Owen N. Witte*‖ murine X-linked immunodeficiency (Xid). XLA patients
have a deficit in mature B cells due to a developmental*Department of Microbiology and Molecular Genetics
University of California, Los Angeles arrest during pre-B cell expansion (Kinnon et al., 1993).
In Xid, B cell development is selectively impaired andLos Angeles, California 90095-1662
²University of California, Los Angeles the number of B cells is reduced by 30%±50% (Wicker
and Scher, 1986). Xid B cells do not respond normallyCedars Sinai Medical Genetics Training Program
Los Angeles, California 90048 to a wide variety of activating signals, including thymus-
independent type 2 antigens, surface immunoglobulin³Howard Hughes Medical Institute
Department of Medicine M (sIgM) cross-linking, and interleukin-5 (IL-5), IL-10,
CD38, or CD40 receptor ligation (reviewed by WickerCardiovascular Research Institute
and Scher, 1986; Rawlings and Witte, 1995).University of California, San Francisco
Enhancement of catalytic activity in association withSan Francisco, California 94143-0724
tyrosine phosphorylation is involved in the activation of§Laboratory of Allergy and Immunology
many tyrosine kinases (reviewed by Perlmutter et al,Beth Israel Hospital and Harvard Medical School
1993). Btk catalytic activity and tyrosine phosphoryla-Boston, MA 02215
tion increase in response to cross-linking or stimulation‖Howard Hughes Medical Institute
of the sIgM complex, the IL-5 receptor, or the IL-6 recep-Los Angeles, California 90095-1662
tor of B cells, or the high affinity IgE receptor of mastMolecular Biology Institute
cells (Saouaf et al., 1994; de Weers et al., 1994; Aoki etUniversity of California, Los Angeles
al., 1994; Sato et al., 1994; Matsuda et al., 1995; Kawa-Los Angeles, California 90095-1662
kami et al., 1994). Stimulation of the B cell receptor
(BCR) by sIgM cross-linking increases binding of Src
family tyrosine kinases to the BCR and triggers activa-
Summary tion of Src family tyrosine kinases (reviewed by Cambier
et al., 1994). The activation of Src family tyrosine kinases
Bruton's tyrosine kinase (Btk) plays a crucial role in B precedes Btk activation after sIgM cross-linking, sug-
cell development. Overexpression of Btk with a Src gesting that Src family tyrosine kinases may be regula-
family kinase increases tyrosine phosphorylation and tors of Btk activation (Saouaf et al., 1994).
catalytic activity of Btk. This occurs by transphosphor- Vaccinia virus±driven high level coexpression of Btk
ylation at Y551 in the Btk catalytic domain and the with Lyn results in an increase in both Btk catalytic
enhancement of Btk autophosphorylation at a second activity and Btk tyrosine phosphorylation (Rawlings et
site. A gain-of-function mutant called Btk* containing al., 1996). Lyn/Btk coexpression induces Btk phosphor-
E41 to K change within the pleckstrin homology do- ylation at two distinct tyrosine residues by two indepen-
main induces fibroblast transformation. Btk* enhances dent steps. Phosphorylation at Y551 requires Lyn kinase
the transphosphorylation of Y551 by endogenous Src activity, indicating that Y551 is a transphosphorylation
family tyrosine kinasesand autophosphorylation at the site. The sequence surrounding BtkY551 is an excellent
second site. We mapped the major Btk autophosphor- match to the consensus Src family phosphorylation site
ylation site to Y223 within the SH3 domain. Mutation (Hanks, 1988). This transphosphorylation at Y551 is fol-
of Y223 to F blocks Btk autophosphorylation and dra- lowed by phosphorylation at a second site, which is
matically potentiates the transforming activity of Btk* dependent on Btk catalytic activity.
in fibroblasts. The location of Y223 in a potential li- We had previously identified an activated form of Btk,
gand-binding pocket suggests that autophosphoryla- which was isolated using a retroviral random mutagene-
tion regulates SH3-mediated signaling by Btk. sis scheme (Li et al., 1995). Btk* contains a point muta-
tion (E41K) in the PH domain and leads to constitutive
activation of Btk. Btk* can induce transformation of fi-
broblasts and IL-5-independent growth of a pro-B cell
line. The transforming activity of Btk* is associated withIntroduction
an increase in tyrosine phosphorylation and increased
membrane localization of Btk. The transforming activityBruton's tyrosine kinase (Btk) is a member of the Btk/
is dependent on Btk kinase activity and phosphorylationTec subfamily of cytoplasmic tyrosine kinases. Btk con-
of the consensus phosphorylation site of Src family tyro-tains a pleckstrin homology domain (PH) and proline-
sine kinases (Y551) within the Btk catalytic domain. Ki-rich sequences at its N terminus, in addition to the Src
nase-inactive Btk*/K430R lacks tyrosine phosphoryla-
tion but the Btk*/Y551F double mutant accumulates
tyrosine phosphorylation at a low level. These results#These authors contributed equally to this manuscript.
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suggest that Btk*-mediated tyrosine phosphorylation Results
results from at least two phosphorylation events, which
The Btk* Mutation Leads to the Phosphorylationoccur at Y551 and at an unidentified tyrosine residue.
of Two Distinct Tyrosine ResiduesBtk* cannot transform rat-2 fibroblasts to agar growth
by Two Independent Stepsunless it is coexpressed with a weakly activated form
Phosphorylation mapping studies by Rawlings et al.of c±src (srcE378G) (D. E. H. A. et al., submitted). Trans-
(1996) have shown that theSrc family kinase Lyn inducesforming activity correlates with the enhancement of Btk
Btk tyrosine phosphorylation by transphosphorylationtyrosine phosphorylation. Btk*-mediated transformation
of Btk at Y551 and enhancement of autophosphorylationis suppressed by coexpression of the C-terminal Src
at a second site. Phosphorylation at these sites corre-kinase (Csk), which inactivates Src family tyrosine ki-
lates with a greater than 5- to 10-fold increase in Btknases. These results provide genetic evidence for the
catalytic activity. To determine whether activation byrole of Src family kinases as upstream regulators of Btk
Btk* correlated with phosphorylation of the same tyro-signaling. The transforming potential of Btk* is further
sine residues induced by Btk/Lyn coexpression, we ana-enhanced by a block deletion of the SH3 domain of Btk
lyzed the phosphorylation patterns induced by Btk*.(Li et al., 1995; D. E. H. A. et al., submitted). Analogous
Wild-type Btk and Btk* were expressed in NIH 3T3 cellsto other cytoplasmic tyrosine kinases, the SH3 domain
by retroviral infection. Following in vivo 32P-orthophos-of Btk is likely to act as a regulatory domain (Hirai and
phate labeling, Btk proteins were immunoprecipitated
Varmus, 1990; Seidel-Dugan et al., 1992; Jackson et al.,
from cell extracts and analyzed by two-dimensional
1993; Mayer and Baltimore, 1994; Okada et al., 1993).
tryptic phosphopeptide mapping (Boyle et al., 1991).
Using detailed phosphopeptide analysis, we demon-
Btk* contained four major phosphopeptides that were
strate that the Btk* mutation or Lyn/Btk coexpression
not present in wild-type Btk (Figures 1A and 1B). Phos-
induce indistinguishable patterns of tyrosine phosphor- phoamino acid analysis of individual peptides revealed
ylation on Btk. This suggests that alternative modes the presence of phosphotyrosine in the four peptides
of activation generate common signals leading to Btk (py1, py19, py29, and py299). We defined the py1 peptides
tyrosine phosphorylation. We identified the major Btk and py2 peptides as two families of closely related spe-
autophosphorylation site and mapped it to Y223 within cies, since they appear to be derived from peptides
the SH3 domain. Mutation of Y223 to phenylalanine containing the same phosphorylation sites (see below).
strongly potentiates Btk* transforming activity, sug- In addition, Btk* exhibited enhanced phosphorylation of
gesting that autophosphorylation serves to regulate Btk four peptides compared with wild-type Btk. Of these
activation. The Y223 residue is highly conserved among peptides with enhanced phosphorylation, three con-
the SH3 domains of a broad array of signaling proteins tained phosphoserine (ps1, ps2, and ps3) and one con-
and is proposed to lie in the surface of the ligand-binding tained phosphotyrosine (py2). Analysis of wild-type Btk
groove (Koyama et al., 1993; Noble et al., 1993; Feng et showed a prominent phosphothreonine-containing pep-
al., 1994; Erpel et al., 1995). Thus, Y223 of Btk is likely tide (pt1), which was significantly reduced in Btk*.
to have a critical role in SH3 function of Btk by regulating To test which phosphopeptides represent autophos-
phorylation or transphosphorylation sites, we analyzedprotein±protein interactions.
Figure 1. Comparison of Two-Dimensional
Tryptic Peptide Map of Btk Proteins
(A) Wild-type Btk, (B) Btk*, (C) Btk*/Y551F, (D)
Btk*/K430R Btk proteins were stably ex-
pressed inNIH 3T3 cells by retroviral infection
(see Experimental Procedures). Cells (1 3 107)
were incubated with 1 mCi/ml 32P-orthophos-
phate in 2 ml of phosphate free DMEM for
3 hr. Btk proteins were immunoprecipitated
using affinity-purified antibodies specific to
the N-terminal region of Btk (N2) (Tsukada et
al., 1993; Li et al., 1995), separated by SDS±
PAGE, blotted onto nitrocellulose, and di-
gested with trypsin. The tryptic peptides were
oxidized with performic acid and separated
by thin-layer electrophoresis at pH 1.9 fol-
lowed by chromatography (Boyle et al., 1991).
Phosphopeptides were detected by autoradi-
ography, eluted from the thin-layer cellulose
plate, and subjected to phosphoamino acid
analysis (Boyle et al., 1991). ps, pt, and py
indicate peptides containing phosphoserine,
phosphothreonine, and phosphotyrosine, re-
spectively.
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Figure 2. IgA Protease Cleavage of Btk
The schematic representation indicates the
structural domains of Btk, the possible sites
of IgA protease cleavage, and the N-terminal
and C-terminal fragments generated by the
IgA cleavage. At the bottom of the figure, par-
tially purified wild-type protein, expressed by
vaccinia virus coinfection with Lyn (see the
Experimental Procedures) was incubated in
the absence (lanes 1, 3, 5) or presence (lanes
2, 4, 6) of IgA protease. The digested frag-
ments were separated by SDS±PAGE, and
Western blot analysis was performed using
polyclonal antisera against the N-terminal
portion (N-term, lanes 1, 2) or C-terminal 15
aa of Btk (C-term, lanes 3, 4), or monoclonal
antibodies against phosphotyrosine (anti-PY,
lanes 5, 6). Full-length (80 kDa), N-terminal
(30 kDa), and C-terminal (50 kDa) fragments
are indicated.
the phosphopeptide patterns of a set of Btk* double Lyn from Btk. Btk protein was eluted from the column
using high salt (0.5 M NaCl), while Lyn was recoveredmutants. Mutants that are either kinase negative (K430R)
or that contain a mutation that abolishes the Src kinase from the flow-through fraction (see Experimental Proce-
dures). Btk protein was digested with IgA protease,consensus phosphorylation site (Y551F) were generated
in conjunction with Btk*. Previous studies by Li et al. which cleaves at two adjacent proline-rich motifs C-ter-
minal to the Btk PH domain, resulting in an N-terminal(1995) showed that either of these mutations reduces
the tyrosine phosphorylation associated with Btk* and and a C-terminal fragment of protein. Western analysis
using antibodies specific for phosphotyrosine, Btk Nsuppresses the transforming activity in fibroblasts. Btk*/
Y551F abolished phosphorylation of py1 but retained terminus, and Btk C terminus revealed that Btk tyrosine
phosphorylation sites were all located in the C-terminalpy2, indicating that the py1 peptide was derived from a
peptide phosphorylated onY551 (Figure 1C). In contrast, fragment, which includes the SH3, SH2, and SH1 do-
mains (Figure 2).the kinase-inactive Btk*/K430R lost phosphorylation of
py2, py29, and py299 but retained phosphorylation of py1 To test whether the Btk autophosphorylation site re-
sides in the SH3 domain, a Btk*/delSH3 double mutant(Figure 1D). Thus, while phosphorylation of Y551 does
not require Btk kinase activity, phosphorylation of all (Li et al., 1995) was stably expressed in NIH 3T3 cells.
Tryptic phosphopeptide mapping revealed that deletionpy2-related peptides is dependent on Btk kinase activ-
ity. This indicates that the three py2 peptides (py2, py29, of the SH3 domain abolished all three py2 peptides
induced by Btk*. In contrast, phosphorylation at py1and py299) contain autophosphorylation sites. The py2
peptide migrates at an identical position to the peptide was unaltered by the SH3 domain deletion (Figure 3A).
In addition, BtkdelSH3 coexpressed with Lyn in NIH 3T3containing the Btk autophosphorylation site following
Btk/Lyn coexpression. These results suggest that Btk* cells retained phosphorylation of py1 (Y551) but lost
phosphorylation of py2. Interestingly, coexpression ofand Btk/Lyn coexpression induce highly related phos-
phorylationpatternscontaining twomajor tyrosinephos- BtkdelSH3 with Lyn resulted in the production of another
peptide containing phosphotyrosine (py3) (Figure 3B).phorylation sites.
The lack of py2 phosphorylation in the absence of the
SH3 domain suggested that the Btk autophosphoryla-The Major Btk Autophosphorylation Site
Resides within the SH3 Domain tion site resides within the SH3 domain. Alternatively,
deletion of the SH3 domain may cause a structuralTo identify the autophosphorylation site in Btk, wild-
type Btk protein was coexpressed with Lyn in NIH 3T3 change in the protein, which prevents autophosphoryla-
tion at a site distal to the SH3 domain. To determinecells using vaccinia virus. Btk was partially purified by
phosphocellulose chromatography, which separates whether the autophosphorylation site resides in the SH3
Immunity
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Figure 3. Phosphopeptide Map of Btk Containing SH3 Deletion
(A) Btk*/delSH3 stably expressed in NIH 3T3.
(B) BtkdelSH3 coinfected with Lyn in NIH 3T3 cells using vaccinia
virus.
(C) In vitro phosphorylated GST±BtkSH3 fusion protein.
Vaccinia virus expressing Btk or Lyn was coinfected into NIH 3T3
cells for 12±15 hr prior to in vivo 32P04 labeling. For in vivo labeling,
1 3 107 cells were incubated with 1 mCi/ml of 32P-orthophosphate
in 2 ml of phosphate-free DMEM for 3 hr. Btk proteins were immuno-
precipitated by affinity-purified Btk antibodies (N2) and digested
with trypsin as described in the Experimental Procedures. GST±
BtkSH3 fusion proteins were expressed in Escherichia coli and iso-
lated as described in Experimental Procedures. GST±BtkSH3 pro-
tein (4 mg) was phosphorylated by 50 ng of purified Btk protein in
vitro in 20 mM PIPES (pH 7.0), 20 mM MnCl2, 10 mM ATP, and 100
mCi of [g±32P]ATP at 308C for 1 hr. In vitro phosphorylated GST±
BtkSH3 was resolved by SDS±PAGE, transferred onto nitrocellulose
membrane, and digested by trypsin. The tryptic peptides were sepa-
rated by thin-layer electrophoresis at pH 1.9, followed by chroma-
tography (Boyle et al., 1991). The locations of py2 and py29 peptides
are indicated.
domain, GST±BtkSH3 fusion protein was used as a sub-
strate for purified Btk in in vitro kinase assays. Full-
length Btk containing a histidine tag at the C terminus
was purified to near homogeneity by phosphocellulose
chromatography and a Ni21±NTA affinity column (see
Experimental Procedures). Btk was able to phosphory-
late GST±SH3 but not GST protein alone (data not
shown). Two tryptic phosphopeptides were recovered
from phosphorylated GST±SH3 protein whose migration
patterns were indistinguishable from py2 and py29 pep- Figure 4. Physical Mapping of the Btk Autophosphorylation Site
tides derived from the Btk* protein (Figure 3C). Taken
(A) Strategy for mapping the Btk autophosphorylation site. NIH 3T3
together, these results strongly suggest that a major Btk cells were coinfected with BTKY551F and Lyn vaccinia virus con-
autophosphorylation site(s) is located within the Btk SH3 structs, labeled with 32P-orthophosphate, partially purified by phos-
domain. phocellulose chromatography, and then immunoprecipitated by af-
finity-purified Btk antibodies (N2) as described in the Experimental
Procedures. Immunoprecipitates were separated by SDS±PAGE,Y223 Is the Major Btk Autophosphorylation Site
blotted onto nitrocellulose, and digested with trypsin. The trypticRawlings et al. (1996) demonstrated that BtkY551F
peptides containing phosphotyrosine were isolated using an anti-
coexpressed with Lyn retains the autophosphorylation phosphotyrosine column, separated by HPLC, and subjected to
site contained in py2 but loses py1 (containing Y551). automated Edman peptide sequence analysis for 10 cycles as de-
To identify the tyrosine autophosphorylation site by scribed.
(B) HPLC profile and the amino acid sequences of phosphotyrosinephysical mapping, phosphorylated py2 peptide was en-
containing peptides. At the top of the figure, the schematic diagramriched by coexpression of BtkY551F with Lyn by vac-
of Btk indicates the domain structure of Btk, the location of tyrosinecinia virus in NIH 3T3 cells. Following in vivo labeling with
223 within the SH3 domain, and the location of tyrosine 551 within32P-orthophosphate, purified Btk protein was digested the SH1 domain. A portion of the primary amino acid sequence of
with trypsin and phosphotyrosine-containing peptides Btk within the SH3 domain is shown. At the bottom of the picture,
were isolated using an anti-phosphotyrosine antibody the HPLC elution profile demonstrates the separation of phosphoty-
rosine containing tryptic peptides. The anti-phosphotyrosine eluatecolumn. The peptides were separated by reverse phase
was separated using a C18 reverse phase HPLC and eluted with ahigh pressure liquid chromatography (HPLC) and radio-
linear acetonitrile gradient of 5%±27% as described in the Experi-activity in each fraction was measured (Figure 4A). One
mental Procedures. Radioactivity in each HPLC fraction was mea-
major peak (B) and one minor peak (A) (Figure 4B) were sured (cpm). Two major peaks containing 32P were indicated as A
independently subjected toautomated Edman degrada- and B. Peak fractions containing A or B were pooled, dried, and
tion analysis for 10 cycles. Sequence analysis revealed
that peptides A and B contain overlapping sequences
Regulation of Btk by Autophosphorylation
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within the SH3 domain. Peptide B originated from a
predicted tryptic digestion site. However, peptide A was
derived from a cleavage at L222, which probably was
generated by contaminating protease activity in the tryp-
sin preparation. Independent microsequencing analysis
of these two fractions showed preferential loss of posi-
tion Y223, indicating it is the only phosphotyrosine-mod-
ified residue in either peptide (Figure 4B).
Since the predicted tryptic peptide containing the Btk
autophosphorylation site has another tyrosine residue,
Y225, it is possible that generation of multiple py2 pep-
tides arose from differential phosphorylation on two dif-
ferent tyrosine residues in the same tryptic peptide. To
test this possibility, the tryptic peptides derived from
in vitro phosphorylated GST±SH3 protein by Btk were
sequenced directly. Following trypticdigestion of invitro
phosphorylated GST±BtkSH3 fusion protein, phospho-
tyrosine containing peptides were isolated on an anti-
phosphotyrosine antibody column, separated by HPLC
fractionation, and subjected to 12 cycles of automated
Edman sequence analysis. The results showed that only
Y223 was phosphorylated in each peptide. Thus, the
different migration properties of py2 peptides do not
result from differential phosphorylation of the same
tryptic peptide, but are likely due to the generation of
heterogeneous products by contaminating proteases.
Conceivably, they could arise from additional protein
modifications that occur within the same phospho-
peptide.
Mutation of Y223 Potentiates Btk*
Transforming Activity
Btk* is a weak transforming allele in rat fibroblasts com-
pared with NIH 3T3 cells. However, Btk*-transforming
activity is dramatically potentiated by coexpression with
a weakly activated form of c±src (srcE378G) in rat-2
cells. srcE378G contains an activating mutation in the
catalytic domain (Levy et al., 1986) but does not trans-
form rat-2 cells (D. E. H.A. et al., submitted). The synergy
Figure 5. Effect of Y223F Mutation in Btk* Transforming Activitybetween Btk* and srcE378G correlates with a significant
Parental rat-2 cells and cells expressing SrcE378G were infectedincrease in Y551 phosphorylation and enhanced Btk
with retroviruses encoding wild-type Btk, BtkY223F, Btk*, or Btk*/autophosphorylation. Btk*-transforming activity is fur-
Y223F and were plated into soft agar in medium containing 20%ther enhanced by a block deletion of the SH3 domain
fetal calf serum at 1 3 104 cells/plate. Colonies equal to and larger
when coexpressed with srcE378G. This supports the than 0.5 mm in diameter were counted after 3 weeks in soft agar.
role of the Btk SH3 domain in regulating Btk activity The approximate locations of point mutations in the Btk subdomain
(D. E. H. A. et al., submitted). are indicated by arrows in the schematic representations of the
different Btk forms. The number of colonies are indicated and repre-We tested whether the point mutation of Y223 to phe-
sent averages from two different independent experiments. The pic-nylalanine, which cannot serve as a phosphate ac-
tures were taken after colonies were grown for 3 weeks in agar.ceptor, stimulates or inactivates Btk*-mediated trans-
formation. If Btk autophosphorylation inactivates SH3
function similar to a deletion of the SH3 domain, muta-
These Btk forms were introduced into either rat-2 cellstion of Y223 would activate Btk signaling leading to
or rat-2 cells coexpressing srcE378G. Tryptic phospho-enhanced Btk* transformation. Alternatively, if Btk auto-
peptide mapping of in vivo 32P-labeled Btk moleculesphosphorylation serves as an activation mechanism,
showed that the Y223F mutation abolished phosphory-then mutation of Y223 would reduce Btk* transforma-
lation of py2 peptides (data not shown).tion. To test these possibilities, the Y223F mutation was
Rat-2 cells expressing wild-type Btk or Btk* formedgenerated in the context of wild-type Btk and Btk*.
only a low number (<10) of small colonies (<0.5 mm
diameter) per 104 cells plated in soft agar (Figure 5). As
previously shown, coexpression of Btk* with SrcE378G
subjected to 10 cycles of automated Edman degradation sequence
in rat-2 cells resulted in the growth of numerous (>350),analysis. PH, pleckstrin homology domain; SH, src homology do-
medium- to large-sized colonies (0.5±1.5 mm in diame-mains; pro, proline-rich sequences. Locations of Y223 and Y551 are
indicated. ter) in agar after 3 weeks in culture. Mutation of Y223
Immunity
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Table 1. Differences in Transforming Activity of Btk* and Btk*/Y223F
Number of Colonies in Soft Agar
Rat-2 cells 5% Serum Number of Cells Plates (3 103) 20% Serum Number of Cells Plates (3 103)
plated in
soft agar 2 5 10 2 5 10
Mock ,10 ,10 ,10 ,10 ,10 ,20
BTK* 90 140 230 160 260 420
BTK*Y223F 300 500 .800 560 .800 .800
Rat-2 cells expressing SrcE378G were infected with retroviruses encoding Btk* or Btk*/Y223F. Cells (2 3 103, 5 3 103, or 1 3 104) were plated
in soft agar in either 5% or 20% fetal calf serum. The growth of colonies in soft agar was allowed to proceed for 3 weeks, at which time the
colonies larger than 0.5 mm in diameter were counted. The transforming strength was discernible between Btk* and Btk*/Y223F within 10
days after plating in soft agar.
in Btk* resulted in a dramatic increase in number (>800) 3). Btk*/Y223F exhibited a small increase in kinase activ-
ity (<2-fold) compared with Btk* in both autophosphor-and sizeof colonies (1.0±1.5 mm in diameter) when coex-
pressed with SrcE378G (Figure 5). Btk*/Y223F induced ylation and transphosphorylation reactions (Figure 6,
lane 4).more rapidly the appearance of colonies and the acidifi-
cation of the media (within 2 weeks) than Btk* did (within We also compared the transphosphorylation activity
between Btk* and Btk*/Y223F using a synthetic peptide3±4 weeks).
To quantify better the difference in transforming activ- of 12 aa containing sequences surrounding Y223 as
a substrate. The transphosphorylation activity of Btk*/ity between Btk* and Btk*/Y223F, rat-2 cells coexpress-
ing these Btk mutants with SrcE378G were plated in Y223F was slightly elevated compared with Btk* (<2-
fold), which was consistent with the enolase phosphory-soft agar at three different cell concentrations in either
5% or 20%serum (Table 1). Cells expressing Btk*/Y223F lation results (data not shown). This demonstrates that
the Y223F mutation does not dramatically enhance Btkformed at least three times more colonies than cells
expressing Btk* under all conditions (Table 1). kinase activity. Thus, increase in transforming activity
In separate experiments, NIH 3T3 cells were infected
with retroviruses encoding wild-type Btk, BtkY223F,
Btk*, or Btk*/Y223F and plated in soft agar at 1 3 104
cells/plate in 5% or 20% serum. Btk wild-type or
BtkY233 did not induce agar colony formation. Cells
expressing Btk*/Y223F formed numerous (>800), large-
sized (1.0±2.0 mm indiameter) colonies within 3±4 weeks
after plating. Cells expressing Btk* gave rise to only a
few (50±100), medium-sized colonies under these condi-
tions (data not shown).
Y223F Mutation Does Not Significantly Affect
Btk Kinase Activity
The increase in biological activity of Btk*/Y223F may be
explained by a dramatic increase in Btk kinase activity,
which is illustrated in the cases of transforming mutants
of abl and src oncogenes (Coussens et al., 1985; Iba et
al., 1985; Konopka and Witte, 1985; Lugo et al., 1990).
To test whether the Y223F mutation enhances tyrosine
kinase activity, we compared the in vitro kinase activity
of Btk in the presence or absence of Y223F mutation.
Wild-type Btk, BtkY223F, Btk*, Btk*/Y223F, and kinase-
inactive Btk*/K430R were coexpressed with SrcE378G
in rat-2 cells. Btk proteins were immunoprecipitated and
Figure 6. Tyrosine Kinase Activities of Btk* or Btk*/Y223F Coex-
analyzed for autokinase and transphosphorylation activ- pressed with SrcE378G
ity using enolase as a substrate. Btk*/K430R exhibited
Rat-2 cells expressing SrcE378G were infected with retrovirusesno autokinase and very low transphosphorylation activ-
encoding wild-type Btk (lane 1), BtkY223F (lane 2), Btk* (lane 3),
ity (Figure 6, lane 5). This indicates that the immunopre- Btk*/Y223F (lane 4), and kinase-inactive Btk*/K430R (lane 5). Btk
cipitates were largely free of contaminating kinases. proteins were immunoprecipitated from 1 3 107 cells using antibod-
ies directed against Btk (N2). Btk autokinase as well as transphos-When the extent of phosphorylation is normalized to
phorylation activity using enolase as a substrate (2 mg/reaction) wasthe amount of protein present in each kinase assay,
measured in 20 mM PIPES (pH 7.0), 20 mM MnCl2, 20 mM ATP, 10BtkY223F had similar autokinase and transphosphoryla-
mCi of [g±32P]ATP at 308C for 10 min. Phosphorylated proteins weretion activities compared with wild-type Btk (Figure 6,
resolved by SDS±PAGE and detected by autoradiography. The level
lanes 1 and 2). As previously shown by Li et al. (1995), of Btk proteins was analyzed by Western blot analysis of the immu-
the in vitro autokinase activity of Btk* protein was not noprecipitates using anti-Btk antibodies (N2) (aBtk). The positions
of Btk and enolase are indicated by arrows.enhanced compared with wild-type Btk (Figure 6, lane
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of Btk*/Y223F is most likely due to an alteration in signal Kinetic studies by Saouafet al. (1994) showed sequen-
tial activationof cytoplasmic tyrosine kinases upon sIgMtransduction mediated in some manner by the SH3
domain. cross-linking of B cells. Btk activation follows that of
Lyn and Blk, while Syk becomes activated gradually
following Btk activation. This suggested that Btk tyro-
Discussion sine phosphorylation in B cells may be dependent on
activation of Src family tyrosine kinases. Genetic analy-
A Two-Step Mechanism for Btk sis of animals carrying null alleles of Fyn or Lyn demon-
Tyrosine Phosphorylation strate the specific role of these src family tyrosine ki-
In this report, we show that two different modes of acti- nases in Btk signaling. Although Fyn knockout animals
vation lead to phosphorylation of the same two tyrosine do not display any severe abnormality in B cell develop-
residues of Btk. The same tyrosine phosphorylations ment, B cells derived from these animals are defective
can be induced upon sIgM cross-linking of a human B in IL-5 signaling (Appleby et al., 1995). B cells from Lyn
cell line (Rawlings et al., 1996), which correlates with knockouts show impaired response to sIgM stimulation
enhancement of Btk autokinase activity. While phos- and lack of B-1 B cell production (Hibbs et al., 1995).
phorylation of Btk at Y551 by Src family kinases is crucial Btk knockout animals display an Xid phenotype with
for activating Btk function, it is not yet clear how phos- impaired responses in IL-5 and sIgM signaling (Khan et
phorylation at Y223 regulates Btk signaling in B cells. al., 1995; Kerner et al., 1995). Thus, Lyn and Fyn appear
Contrary to a recent report by Mahajan et al. (1995), to participate in distinct Btk-mediated signaling during
we demonstrate that Y551 is a transphosphorylation B cell development.
site. They argue that Y551 is a major Btk autophosphory-
lation site, since a Y551F mutation abolishes Btk tyro-
SH3 Domain in Btk Signalingsine phosphorylation in their experiments. However, we
Autophosphorylations of Src family and receptor tyro-have observed that the Y551F mutant immunoprecipi-
sine kinases occur in their catalytic domains and en-tated from NIH 3T3 cells is still kinase active and be-
hance their enzymatic activities (reviewed by Coopercomes autophosphorylated at othersites (Li et al., 1995).
and Howell, 1993; Kazlauskas, 1994). In contrast, theThe discrepancy may be due to different expression
major Btk autophosphorylation site is mapped to Y223levels of catalytically active Btk proteins in two indepen-
in the SH3 domain. The precise role of the Btk SH3dent experimental settings. Our mapping studies and
domain in signaling and its ligand specificity is notmutational analyses clearly illustrate that the major Btk
known. Mutations in the SH3 domain of c±src or c±ablautophosphorylation occurs at Y223, which resides in
increase their transforming potentials, suggesting thata distinct peptide from that containing Y551. Mahajan
their SH3 domains have a role in down-regulation ofet al. (1995) showed that CNBr cleavage of autophos-
their kinase activity (Jackson and Baltimore, 1989; Franzphorylated Btk yielded a single-sized phosphopeptide
et al., 1989; Hirai and Varmus, 1990; Jackson et al., 1993;that they thought was phosphorylated only at Y551.
Mayer and Baltimore, 1994; Okada et al., 1993). DeletionHowever, CNBr cleavage of Btk protein can generate
of the Btk SH3 domain enhances Btk*-mediated trans-two peptides of about 7 kDa containing either Y551 (61
formation of fibroblasts upon stimulation by SrcE378Gaa from D510±M570) or Y223 (63 aa from G164±M226).
(D. E. H. A. et al., submitted). Since deletion or mutationSince these two peptides could not be resolved by one-
of the Btk SH3 domain does not appear to affect Btkdimensional SDS±PAGE, the peptides derived from au-
kinase activity directly, it is likely to regulate Btk functiontophosphorylated Btk by CNBr cleavage in their report
by binding to regulatory molecules.likely contain species phosphorylated at Y551 and Y223.
SH3 domains bind to peptides containing proline-rich
sequences. The SH3 domain core is composed of two
perpendicular and antiparallel three-stranded b-pleatedRole of Src Family Tyrosine Kinases
in Btk Activation sheets. The hydrophobic surface contains shallow
grooves formed by highly conserved aromatic aminoThe Btk* mutation increases membrane localization of
Btk (Li et al., 1995). A recent structural study shows that acids that contact proline-rich peptides. Recent struc-
tural and mutational analyses of SH3 domains from aPIP2 binds to the PH domain at the site of the Btk*
mutation (E41K) (Ferguson et al., 1995). This suggests wide range of signaling molecules identified important
residues involved in these protein±protein interactionsthat Btk* may alter the binding affinity of the Btk PH
domain to specific phosphoinositol lipids that may aid (Knudsen et al., 1995; Maignan et al., 1995; Goudreau
et al., 1994; Terasawa et al., 1994; Yu et al., 1994; Koy-Btk association with membranes. We have demon-
strated that activation of Src family tyrosine kinases ama et al., 1993; Kohda et al., 1993; Lim et al., 1994;
Feng et al., 1994). Based on structural comparison withpotentiate Btk* transforming activity, while suppression
of Src family tyrosine kinases by Csk diminishes Btk* the Fyn SH3 domain, Btk Y223 represents one of the
highly conserved aromatic residues forming the surfaceactivation (D. E. H. A. et al, submitted). This data sup-
ports the idea that Src family tyrosine kinases act as of the peptide-binding groove (Noble et al., 1993). Muta-
tional analysis of the c±src SH3 domain demonstratedupstream regulators of Btk. In this assay, Src kinases
show synergy only with Btk* not with wild-type Btk. Btk* that Y90 of c±src (equivalent to Btk Y223) is critical for
SH3-mediated protein±protein interactions (Erpel et al.,is presumably more accessible to activated Src kinases,
which results in enhanced tyrosine phosphorylation and 1995). Thus, Y223 of Btk is highly likely to play a crucial
role in ligand binding.Btk activation.
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prepared by transient transfection of 293T cells (Muller et al., 1991;Function of Phosphorylation at Y223
Pear et al, 1993) and were used to infect NIH 3T3 cells. Stable cellin the SH3 Domain
lines expressing Btk were generated by selection in G418. Recombi-Phosphorylation of a tyrosine residue in the SH3 domain
nant vaccinia viral constructs expressing Lyn or BtkdelSH3 were
of c±src has been recently implicated as a mechanism produced as described previously (Rawlings et al., 1996).
of regulating SH3-mediated signaling. The Y138 residue
of the c±src SH3 domain (equivalent to Y263 of Btk) has Construction of GST±BtkSH3 Fusion Protein
Polymerase chain reaction was performed to amplify the regionbeen shown to be phosphorylated by the PDGF receptor
encoding the SH3 domain (nucleotides 787±951) from murine Btk(M. Broome and T. Hunter, personal communication).
cDNA using the primers SH3-59 (59-GTGGATCCAAGGTCGTGGCCCThe Y138F mutation acts as a dominant negative inhibi-
TTTAT-39) and SH3-39 (59-CCGAATTCTGTAGCCTTCCTGCCCAT).
tor of PDGF-stimulated mitogenesis without inhibiting The polymerase chain reaction product was cloned into pGEX-2T
Src catalytic activity (M. A. Broome and T. Hunter, sub- (Pharmacia Biotech). The fusion protein was induced and purified
mitted). Interestingly, phosphorylation at Y138 signifi- as described previously (Frangioni and Neal, 1993).
cantly diminishes SH3 binding affinity for peptide li-
Site-Directed Mutagenesisgands containing proline-rich sequences, suggesting a
An EcoRI fragment of Btk (nucleotides 136±1457) containing therole for this phosphorylation in SH3-mediated ligand
Btk* mutation was cloned into M13mp18 vector and single-stranded
binding. DNA was generated. Site-directed mutagenesis was performed on
We have shown that mutation of Y223 of Btk potenti- single-stranded DNA template using an oligomer (59-ATGTAATCGA
ates Btk* transforming activity. A block deletion of the AAAGGGCCA-39) containing phenylalanine at theY223 position (Am-
ersham). DNA sequencing was performed to verify the presence ofSH3 domain of Btk* induces a similar phenotype, sug-
the Y223F mutation. Constructs containing BtkY223F or Btk*/Y223Fgesting that mutation of Y223 is equivalent to inactiva-
were generated in the pSRaMSVtk±neo vector (Muller et al., 1991)tion of SH3 function. This leaves us with two alternative
and were transfected into 293T cells to generate helper-free retro-interpretations. First, activation of Btk by phosphory-
virus.
lation at Y551 leads to autophosphorylation at Y223,
which would down-regulate Btk activity. In this case, In Vivo 32P04-Labeling, Two-Dimensional Tryptic
mutation of Y223 would prevent down-regulation of Btk Phosphopeptide Mapping, and Phosphoamino
Acid Analysisby autophosphorylation and result in activation of Btk
Cells (1 3 107) were used for 32P-orthophosphate labeling. To allowfunction. Alternatively, both mutation of Y223 or phos-
sufficient protein expression, vaccinia viruses encoding Btk werephorylation at Y223 may alter SH3 function and lead to
infected into 1 3 107 NIH 3T3 cells 12±15 hr prior to in vivo 32P-labeling
activation of Btk signaling. Since the Y223F mutation (Rawlings et al., 1996). Cells were washed with phosphate-free
does not significantly change Btk catalytic activity, it is DMEM and labeled with 1 mCi/ml of 32P-orthophosphate (New En-
likely that in either case Y223 in the SH3 domain regu- gland Nuclear) in 2 ml of phosphate-free DMEM for 3 hr. Cell extracts
were prepared in lysis buffer (20 mM HEPES [pH 7.4], 100 mM NaCl,lates Btk activity by modulating binding to cellular regu-
3% Triton X-100, 10% glycerol, 2 mM EDTA, 1 mM Na3V04, 10 mMlatory molecules. One must certainly include the possi-
NaF, and protease inhibitors including 1 mM PMSF, 5 mg/ml aproti-bility that phosphorylation of Y223 creates a docking
nin, and 5 mg/ml leupeptin). Btk was immunoprecipitated with 20
site for a SH2 containing protein or proteins.
mg of affinity-purified antibody (N2), which specifically recognizes
A genetic study in C. elegans implicates the SLI-1 the N-terminal portion of Btk (Tsukada et al., 1993; Li et al, 1995).
gene product, a homolog of mammalian c±cbl, as a Immunoprecipitates were separated by SDS±PAGE (6% polyacryl-
amide), blotted onto nitrocellulose membrane, and visualized bynegative regulator of a receptor tyrosine kinase pathway
autoradiography. Btk protein was excised from the membrane and(Yoon et al., 1995). This suggests a similar role for c±cbl
digested with 15 mg TPCK±trypsin (Sigma) twice for 3 hr at 378C inin down-regulating tyrosine kinase signaling pathways
50 mM NH4HCO3, lyophilized, and treated with performic acid atin mammalian cells. Recently, it was reported that a GST 48C for 1 hr (Luo et al., 1991). Two-dimensional analysis of tryptic
fusion protein containing the SH3 domain of Btk can peptides was performed by thin-layer electrophoresis at pH 1.9,
bind to the c±cbl protooncogene product from B cell followed by chromatography in phosphochromatography buffer
(Boyle et al., 1991). For phosphoamino acid analysis, peptides wereextracts (Cory et al., 1995). It is not known whether full-
extracted from thin-layer cellulose plates using pH 1.9 electrophore-length Btk is able to interact with c±cbl. Autophosphory-
sis buffer and hydrolyzed for 1 hr at 1108C in 6 Na±HCl. 32P-labeledlation at Y223 is predicted to increase negative electro-
amino acids were mixed with phosphoamino acid standards and
static potential and perturb the hydrophobic nature of separated by thin layer electrophoresis at pH 3.5 (Boyle et al., 1991).
the ligand-binding surface of the SH3 domain. This is Standards were developed by ninhydrin staining and 32P-labeled
likely to attenuate binding of proline-rich peptides to amino acids were identified by autoradiography.
the SH3 domain. Btk autophosphorylation substantially
Large Scale Purification of Btk from Vacciniaincreases upon B cell activation but the role of Btk auto-
Virus±Infected Cellsphosphorylation in B cell signaling is not known. A fur-
NIH 3T3 cells (2 3 109) were coinfected with vaccinia viruses ex-ther search for B cell proteins that interact with subdo-
pressing BtkY551F and Lyn. After a 12±18 hr infection, 5 3 107 cells
mains of Btk should provide candidate regulators of Btk were washed with phosphate-free DMEM and incubated with 10±20
function. mCi of 32P-orthophosphate in 5±10 ml of phosphate-free DMEM plus
0.1% dialyzed fetal calf serum for an additional 4±6 hr. Cells were
treated with 200 mM of Na3VO4 1 hr prior to harvesting and lysed inExperimental Procedures
the lysis buffer as described in the previous section. Cell extracts
were applied to a phosphocellulose column (Whatman) and washedCell Culture and Retrovirus or Vaccinia
Virus±Mediated Transfer with buffers containing low salt and detergent (50 mM Tris [pH 7.4],
150 mM NaCl, 0.1% Triton X-100, 10% glycerol, 1 mM Na3V04),NIH 3T3 cells were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% calf serum. Recombinant Btk was medium salt anddetergent (300mM NaCl), low salt with nodetergent
(150 mM NaCl), and then eluted with high salt buffer without deter-cloned into the retroviral expression vector, pSRaMSVtk±neo, as
described by Li et al., (1995). Helper-free retroviral stocks were gent (500 mM NaCl). By immunoblot analysis, Btk was observed to
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elute with 500 mM NaCl, while Lyn was recovered in the initial flow- samples were plated in duplicate in medium containing either 5%
or 20% fetal calf serum. Colonies equal to or larger than 0.5 mm inthrough fraction. The phosphocellulose eluate was concentrated
through a Centricon C-30 filter (Amicon) and stored at 2208C with diameter were counted 2±4 weeks after plating.
25% glycerol. Btk was immunoprecipitated with affinity-purified an-
tibodies (N2) from the phosphocellulose eluate, separated by SDS± In Vitro Btk Kinase Assay
PAGE, blotted onto nitrocellulose, and visualized by autoradiogra- Rat-2 cells expressing SrcE378G were infected with retroviruses
phy. Btk protein was digested with 15±25 mg of TPCK±trypsin twice encoding different forms of Btk. Cell extracts were prepared in lysis
for 90 min at 378C, dried, and resuspended in ddH2O. The tryptic buffer (20 mM Tris [pH 7.4], 150 mM NaCl, 1% Triton X-100, 2 mM
peptides were denatured at 908C for 10 min and then applied to EDTA, 1mM Na3V04, 10 mM NaF, and protease inhibitors including
an anti-phosphotyrosine column (1G2-Sepharose). The column was 1 mM PMSF, 5 mg/ml aprotinin, and 5 mg/ml leupeptin) and Btk was
washed with 50 mM ammonium acetate (pH 7.0), and then eluted immunoprecipitated by antibodies recognizing Btk (N2). Immuno-
with 50 mM ammonium acetate and 500 mM acetic acid (pH 3.7). precipitates were washed four times in lysis buffer and the kinase
activity of Btk proteins was measured in kinase buffer (20 mM PIPES
HPLC Purification of Tryptic Peptides [pH 7.0], 20 mM MnCl2, 20 mM ATP, 10 mCi of [g±32P]ATP) including
and Peptide Sequencing 2 mg of enolase as an exogenous substrate for 15 min at 308C. The
The eluate from the anti-phosphotyrosine column was concentrated reaction mixtures were boiled in SDS sample loading buffer and
to 250 ml and applied to a Betasil C18 250 mm 3 4.6 mm reverse separated by SDS±PAGE (8%). Phosphorylated proteins were de-
phase HPLC column (Keystone Scientific), using a flow rate of 1.25 tected by autoradiography. The level of Btk protein was measured
ml/min. After a 10 min wash at 5% acetonitrile, the phosphopeptides by Western blot analysis using antibodies against Btk (N2).
were eluted with a linear acetonitrile gradient of 5%±27%. Fractions
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